Kimberly Stack
Psychiatric/Mental Health · Clifton Park, NYNPI 1366413536
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 45.6% of the total. Reporting peaked in 2021 at $4,263 and has fallen 72.3% since, to $1,179 in 2025. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $30.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$5K
- AbbVie$2K
- Johnson & Johnson$539
- Teva Pharmaceuticals USA, Inc.$536
- Otsuka America Pharmaceutical, Inc.$411
- Axsome Therapeutics, Inc.$403
- plus $2K from 26 others
What the payments were for
- Consulting fees$1,31312%
- Speaking & faculty fees$3,18830%
- Food & beverage$6,22358%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 37 | $4,890 |
| AbbVie | 97 | $1,557 |
| Johnson & Johnson | 30 | $539 |
| Teva Pharmaceuticals USA, Inc. | 26 | $536 |
| Otsuka America Pharmaceutical, Inc. | 17 | $411 |
| Axsome Therapeutics, Inc. | 17 | $403 |
| Corium, LLC | 22 | $348 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $254 |
| Sunovion Pharmaceuticals Inc. | 15 | $253 |
| Novo Nordisk | 8 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $163 |
| Bausch Health US, LLC | 7 | $151 |
| Ironshore Pharmaceuticals Inc. | 7 | $138 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $120 |
| Lundbeck LLC | 5 | $112 |
| Supernus Pharmaceuticals, Inc. | 6 | $108 |
| Idorsia Pharmaceuticals US Inc | 4 | $84 |
| Lilly USA, LLC | 4 | $76 |
| Amgen | 2 | $56 |
| Alkermes, Inc. | 2 | $45 |
| Exact Sciences | 2 | $44 |
| GSK | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Indivior Inc. | 1 | $29 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Vertex | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Almatica Pharma LLC | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,723 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 15 | $10,049 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 32 | $1,565 |
| Duloxetine Hcl | 26 | $458 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $447 |
| Mirtazapine | 18 | $360 |
| Alprazolam | 22 | $290 |
| Buspirone Hcl | 16 | $242 |
| Alprazolam ErAlprazolam | 11 | $217 |
| Trazodone Hcl | 18 | $161 |
| Lamotrigine | 12 | $145 |
| Clonazepam | 12 | $90 |
| Fluoxetine Hcl | 18 | $49 |
| Sertraline Hcl | 21 | $42 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $163 | $10,04915 claims |
| Almatica Pharma LLCSertraline Hcl | $16 | $4221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Clifton Park
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
- Alexis CrisafiFishkill$70K
- Vera ImperialeAlbany$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.